Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Almoosa Health CoSAU:4018 +0.25%14 Return-on-Tangible-Equity is 4.90% as of Mar. 2026, which is 63% below its 10-year median of 13.38. GuruFocus rates SAU:4018 with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Almoosa Health Co ranks better than 51.9% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Almoosa Health Co's annualized net income for the quarter that ended in Mar. 2026 was ﷼94 Mil. Almoosa Health Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ﷼1,918 Mil. Therefore, Almoosa Health Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 4.90%.
The historical rank and industry rank for Almoosa Health Co's Return-on-Tangible-Equity or its related term are showing as below:
SAU:4018'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.07 Med: 13.38 Max: 18.68
Current: 10.91
During the past 3 years, Almoosa Health Co's highest Return-on-Tangible-Equity was 18.68%. The lowest was 8.07%. And the median was 13.38%.
SAU:4018's Return-on-Tangible-Equity is ranked better than 51.9% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs SAU:4018: 10.91
Almoosa Health Co (SAU:4018) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Almoosa Health Co Return-on-Tangible-Equity Related Terms
Almoosa Health Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Almoosa Health Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4018 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Almoosa Health Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almoosa Health Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Almoosa Health Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Almoosa Health Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.90% mean?
Almoosa Health Co (SAU:4018) has a Return-on-Tangible-Equity of 4.90% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Almoosa Health Co and its competitors. This is 63% below median its historical median of 13.38. Over the past decade, Almoosa Health Co's Return-on-Tangible-Equity has ranged from 8.07 to 18.68. According to the industry distribution chart, Almoosa Health Co ranks #279 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 48.1%.
Is Almoosa Health Co's Return-on-Tangible-Equity too high?
Almoosa Health Co's current Return-on-Tangible-Equity of 4.90% is 63% below median its 10-year median of 13.38. Over the past 10 years, this metric has ranged from a low of 8.07 to a high of 18.68. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. Almoosa Health Co's value of 4.90% is 51.4% below this industry median. Based on the distribution chart, Almoosa Health Co ranks #279 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Almoosa Health Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Almoosa Health Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Almoosa Health Co ranks #279 out of 580 companies for Return-on-Tangible-Equity. This puts Almoosa Health Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.09. Almoosa Health Co's value of 4.90% is 51.4% below this benchmark. Historically, Almoosa Health Co's own Return-on-Tangible-Equity has ranged from 8.07 to 18.68 over the past decade. While the company's 10-year median is 13.38 vs. the industry median of 10.09, Almoosa Health Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almoosa Health Co's current Return-on-Tangible-Equity of 4.90% is 51.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Almoosa Health Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almoosa Health Co's current Return-on-Tangible-Equity is 4.90%, which is 63% below median its own 10-year median of 13.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almoosa Health Co stock overvalued right now?
Almoosa Health Co (SAU:4018) has a current Return-on-Tangible-Equity of 4.90%. The current Return-on-Tangible-Equity is 4.90%, which is 63% below median its 10-year median of 13.38 and 51.4% below the Healthcare Providers & Services industry median of 10.09. Almoosa Health Co's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Almoosa Health Co (SAU:4018), the current Return-on-Tangible-Equity is 4.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Almoosa Health Co provides integrated healthcare services that include primary, acute and rehabilitative care along with ancillary services such as pharmaceuticals, home healthcare and telemedicine. The company is also designing, constructing and developing hospitals care centers. The reported segments are: Medical Services and Hospital: Focused on delivering medical care and treatment; Rehabilitation Centre: Specializing in rehabilitation-related services; Pharmacy: Engaged in the sale of medicines.
14GF Score
Get the complete analysis for SAU:4018
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4018 has been successfully added to your 
